FLORIN BUTUC: Open Payments
NPI 1275188468 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,510 in 15 payments from 11 companies in 2025. Trend: 2023 $741 · 2024 $1,310 · 2025 $1,510
Food & beverage: $1,510
| Company | Payments | Amount |
|---|---|---|
| CorMedix Inc. | 4 | $490 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $187 |
| Amgen Inc. | 1 | $139 |
| Novo Nordisk Inc | 1 | $120 |
| Ardelyx, Inc. | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $96 |
| ANI Pharmaceuticals, Inc. | 1 | $94 |
| Travere Therapeutics, Inc. | 1 | $77 |
| AstraZeneca Pharmaceuticals LP | 1 | $77 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $75 |
Products named: DEFENCATH, KRYSTEXXA, Rivfloza, IBSRELA, PURIFIED CORTROPHIN GEL, Filspari, LOKELMA, Kerendia.
Industry payments across UT — which companies pay providers there.
